BSE Live
Dec 04, 16:01Prev. Close
1638.70
Open Price
1636.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 04, 15:40Prev. Close
1642.20
Open Price
1653.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Hester Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 37.43 | 31.93 | 38.02 | 46.45 | 46.90 | |
| Diluted EPS (Rs.) | 37.43 | 31.93 | 38.02 | 46.45 | 46.90 | |
| Cash EPS (Rs.) | 47.52 | 43.42 | 49.52 | 57.62 | 58.23 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 398.60 | 367.59 | 343.70 | 315.54 | 279.28 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 398.60 | 367.59 | 343.70 | 315.54 | 279.28 | |
| Dividend / Share(Rs.) | 7.00 | 6.00 | 8.00 | 10.00 | 10.00 | |
| Revenue from Operations/Share (Rs.) | 336.74 | 335.20 | 298.58 | 257.85 | 245.07 | |
| PBDIT/Share (Rs.) | 65.48 | 60.66 | 70.78 | 76.67 | 86.57 | |
| PBIT/Share (Rs.) | 55.40 | 49.17 | 59.27 | 65.50 | 75.24 | |
| PBT/Share (Rs.) | 49.09 | 43.18 | 51.63 | 62.60 | 64.40 | |
| Net Profit/Share (Rs.) | 37.43 | 31.93 | 38.02 | 46.45 | 46.90 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 19.44 | 18.09 | 23.70 | 29.73 | 35.32 | |
| PBIT Margin (%) | 16.45 | 14.66 | 19.85 | 25.40 | 30.70 | |
| PBT Margin (%) | 14.57 | 12.88 | 17.29 | 24.27 | 26.27 | |
| Net Profit Margin (%) | 11.11 | 9.52 | 12.73 | 18.01 | 19.13 | |
| Return on Networth / Equity (%) | 9.39 | 8.68 | 11.06 | 14.72 | 16.79 | |
| Return on Capital Employed (%) | 10.48 | 9.25 | 12.31 | 15.93 | 25.87 | |
| Return on Assets (%) | 5.83 | 4.94 | 5.92 | 9.31 | 14.14 | |
| Total Debt/Equity (X) | 0.31 | 0.43 | 0.56 | 0.45 | 0.02 | |
| Asset Turnover Ratio (%) | 0.52 | 0.52 | 0.52 | 0.62 | 73.92 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.92 | 2.09 | 1.58 | 2.22 | 4.03 | |
| Quick Ratio (X) | 1.31 | 1.39 | 1.00 | 1.28 | 2.38 | |
| Inventory Turnover Ratio (X) | 4.51 | 0.44 | 0.39 | 0.55 | 3.66 | |
| Dividend Payout Ratio (NP) (%) | 16.02 | 25.05 | 26.30 | 21.52 | 14.07 | |
| Dividend Payout Ratio (CP) (%) | 12.62 | 18.42 | 20.19 | 17.35 | 11.33 | |
| Earnings Retention Ratio (%) | 83.98 | 74.95 | 73.70 | 78.48 | 85.93 | |
| Cash Earnings Retention Ratio (%) | 87.38 | 81.58 | 79.81 | 82.65 | 88.67 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,168.78 | 1,310.43 | 1,451.81 | 2,429.84 | 1,633.72 | |
| EV/Net Operating Revenue (X) | 4.08 | 4.60 | 5.72 | 11.08 | 7.84 | |
| EV/EBITDA (X) | 20.98 | 25.39 | 24.11 | 37.25 | 22.18 | |
| MarketCap/Net Operating Revenue (X) | 3.72 | 4.14 | 5.09 | 10.53 | 7.82 | |
| Retention Ratios (%) | 83.97 | 74.94 | 73.69 | 78.47 | 85.92 | |
| Price/BV (X) | 3.15 | 3.78 | 4.42 | 8.61 | 6.86 | |
| Price/Net Operating Revenue | 3.72 | 4.14 | 5.09 | 10.53 | 7.82 | |
| Earnings Yield | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 |
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y